Sangart doubles hiring plan to 250; Xcelience and Bend team for formulation, expedited trial supplies;

> San Diego-based biopharma Sangart has doubled its initial plans for staffing a pharma manufacturing plant in Cork, Ireland, bringing the figure to 250. Item 

> Xcelience and Bend Research are collaborating to provide oral solid-solubilization formulation solutions and expedited clinical supply manufacture. Bend Research release

> Specialty drugmaker Alliance Pharma has signed sterile manufacturing expert SCM Pharma for commercial supply of three products. Alliance release

> Rechon Life Science will manufacture and market Zolpimist, an oral spray formulation of zolpidem tartrate, outside North America through a licensing deal with NovaDel Pharma. News

> Specialty formulator Ajanta Pharma has received approval from the U.K. Medicines & Healthcare products Regulatory Agency for a manufacturing plant in Paithan, India. Story

> CDMO Pharmaceutics International has successfully completed a joint European Medicines Agency and FDA inspection. Article

> U.K. plans for a central purchasing system for the seasonal flu vaccine have been strongly criticized by doctors and pharmacists. Story 

> Yourway Transport has launched a BioPharma Services division to be led by Tim Brewer. Yourway release

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.